A diverse hidradenitis suppurativa cohort: A retrospective cross-sectional study of 13,130 patients from a large US health care system database from 1995 to 2022 [0.03%]
美国医疗系统数据库中多样化hidradenitis suppurativa患者的回顾性横断面研究（1995-2022年，共13,130例）
Kelly Z Young,Ian Loveless,Wan-Ting K Su et al.
Kelly Z Young et al.
Background: Most epidemiological studies of hidradenitis suppurativa (HS) have described homogeneous patient populations. Objective: To...
Combined topical 5-fluorouracil and calcipotriene effectively treats superficial keratinocyte carcinomas: A retrospective cohort study from 2 academic centers [0.03%]
外用5-氟尿嘧啶和钙泊三醇联合治疗表皮角质细胞癌：来自两家学术中心的回顾性队列研究
Nicole Loranger,Fatima N Mirza,Truelian Lee et al.
Nicole Loranger et al.
Retrospective analysis of virtual gene panel analysis for genodermatoses reveals a high diagnostic yield in clinical practice [0.03%]
回顾性分析虚拟基因面板在遗传性皮肤病诊断中的应用价值：临床实践具有较高的诊断效能
Aude Beyens,Jozefien Weytens,Lore Pottie et al.
Aude Beyens et al.
Monokine induced by gamma interferon as a marker of systemic hydroa vaccniforme lymphoproliferative disorder [0.03%]
干扰素诱导单核细胞活化因子作为全身性水痘样疹淋巴增生性疾病标志物的研究
Tomoko Miyake,Takenobu Yamamoto,Yoji Hirai et al.
Tomoko Miyake et al.
SpotCheck: A skin cancer diagnostic accuracy study comparing teledermoscopy with and without electrical impedance spectroscopy to in-person dermatologist evaluation of patient-identified lesions concerning them for skin cancer [0.03%]
基于患者自查病灶的远程皮肤镜检查结合和不结合电子阻抗光谱的准确性研究：与面诊皮肤科医生的比较研究
Jenne P Ingrassia,Shirin Bajaj,Avani Kolla et al.
Jenne P Ingrassia et al.
Differentiating seborrheic keratosis from melanoma among lesions exhibiting blue-white veil: A retrospective study [0.03%]
具有蓝色白色伪膜特征的脂溢性角化与黑色素瘤的鉴别诊断：一项回顾性研究
Isabella N Dana,Nicholas R Kurtansky,Larissa M Pastore et al.
Isabella N Dana et al.
Background: Differentiating melanoma (MM) from seborrheic keratosis (SK) containing a blue-white veil (BWV) remains challenging. Objective: ...
No Association Between Adalimumab Use and Heart Failure in Patients with Hidradenitis Suppurativa: A Propensity Matched Study [0.03%]
依那西普的使用与汗腺炎患者心力衰竭无相关性：倾向匹配研究
Haig Pakhchanian,Rahul Raiker,Charles DeYoung et al.
Haig Pakhchanian et al.
Differential patient travel burden to pediatric atopic dermatitis clinical trial sites [0.03%]
特应性皮炎临床试验站点的患者出行负担差异性
Joseph Masison,Eric J Beltrami,Christian Gronbeck et al.
Joseph Masison et al.
Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: Primary results from a randomized phase 2 study [0.03%]
一项随机2期研究中A型肉毒毒素治疗后咬肌突出度降低的主要结果
Jean Carruthers,Steven Liew,Jason K Rivers et al.
Jean Carruthers et al.
Background: OnabotA is used to treat masseter muscle prominence (MMP). Objective: To assess the safety and efficacy of OnabotA for MMP ...
Regarding response to Narayanan et al's "Adverse events in cemiplimab therapy for locally advanced or metastatic cSCC: A global propensity-matched retrospective cohort study" [0.03%]
关于纳拉扬安等人的“赛美铂单抗治疗局部晚期或转移性cSCC的不良事件：一项全球倾向匹配回顾性队列研究”的回复
Kyle C Lauck,Deepika Narayanan,Stanislav N Tolkachjov
Kyle C Lauck